MBA Incorporado, S.L.

MBA Incorporado, S. L. is a company dedicated to distributing innovative medical and surgical technologies, primarily focusing on orthopaedics, traumatology, and various surgical fields to enhance patient outcomes. Founded in 1988 in Gijon, Spain, MBA Incorporado, S.

L. specializes in medical technology distribution. The company was acquired by AddLife AB in December 2021 for EUR 111 million, strengthening their position in advanced surgery in Europe. No significant pivots or additional subsidiaries have been noted.

MBA Surgical Empowerment specializes in the distribution of advanced medical and surgical technologies, focusing on diverse fields such as orthopaedics, traumatology, anaesthesia, surgery, neurosurgery, and radiotherapy. The company provides healthcare professionals with a comprehensive range of solutions designed to enhance patient quality of life through innovative products. Their offerings include surgical support accessories and equipment tailored for specific procedures including hip and knee large reconstruction surgeries, spine surgeries, and trauma care. The company serves a broad client base, including approximately 950 hospitals and 14,000 doctors who utilize their products across markets in Spain, Portugal, and Italy.

Through the MBA Institute, the company further engages in applied clinical research, collaborating with surgeons and scientific entities to continuously improve its product offerings. In the most recent year, MBA Surgical Empowerment generated revenue of EUR 81,533,733. 30, with an EBITDA of EUR 15,188,893. 20.

Their revenue model primarily involves direct partnerships with hospitals and clinics, focusing on the sale of surgical devices and accessories through long-term contracts and supply agreements. Following its acquisition by AddLife AB in December 2021, MBA Incorporado plans to leverage this funding to bolster its presence in advanced surgical technologies across Europe. The company is likely to introduce new product lines designed to enhance surgical outcomes as part of its ongoing innovation strategy. The acquisition is expected to facilitate expansion efforts into new geographic regions, although specific markets and timelines have not been disclosed.